Save your place

Sign in to WhoBought

Please try again later.

Teva Pharmaceutical Industries Limited (TEVA) institutional ownership

Latest close $31.08 Jul 27, 2026
Market cap$39.4B 52-week range SectorHealthcare
Funds holding · Q1 2026
581
reported TEVA position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
326 buyers · 255 sellers

Teva Pharmaceutical Industries Limited (TEVA) price and institutional activity

Dates

Q1 2026

$0 bought by 326 investors
Wcm Investment Management, LLCBlackRock +324 more
$0 sold by 255 investors
NorgesGlenview Capital Management, LLC +253 more
Bought Sold Totals per quarter; hover a bar for the names.

Teva Pharmaceutical Industries Limited (TEVA) institutional activity · 581

Investor Type Est. change Change Δ Own Date
Norges · Exited
Change −35.2M Δ Own −100.0% Date Q1 2026
Norges Exited· Q1 2026 −35.2M −100.0% Q1 2026
Wcm Investment Management, LLC · Added
Change +26.8M Date Q1 2026
Wcm Investment Management, LLC Added· Q1 2026 +26.8M Q1 2026
Glenview Capital Management, LLC · Reduced
Change −10.1M Δ Own −60.2% Date Q1 2026
Glenview Capital Management, LLC Reduced· Q1 2026 −10.1M −60.2% Q1 2026
BlackRock · Added
Change +6.8M Date Q1 2026
BlackRock Added· Q1 2026 +6.8M Q1 2026
Capital World Investors · Added
Change +6.5M Date Q1 2026
Capital World Investors Added· Q1 2026 +6.5M Q1 2026
Rubric Capital Management LP · Reduced
Change −6.1M Date Q1 2026
Rubric Capital Management LP Reduced· Q1 2026 −6.1M Q1 2026
JPMorgan Chase & Co · Added
Change +5.6M Date Q1 2026
JPMorgan Chase & Co Added· Q1 2026 +5.6M Q1 2026
FMR LLC · Added
Change +4.1M Δ Own +14.2% Date Q1 2026
FMR LLC Added· Q1 2026 +4.1M +14.2% Q1 2026
Citadel Advisors LLC Exited· Q1 2026 −3.8M −100.0% Q1 2026
1832 Asset Management L.P. · Exited
Change −3.7M Δ Own −100.0% Date Q1 2026
1832 Asset Management L.P. Exited· Q1 2026 −3.7M −100.0% Q1 2026
Duquesne Family Office LLC Reduced· Q1 2026 −3.5M −59.5% Q1 2026
Schroder Investment Management Group · Reduced
Change −3.1M Date Q1 2026
Schroder Investment Management Group Reduced· Q1 2026 −3.1M Q1 2026
Altshuler Shaham Ltd · Added
Change +3.0M Date Q1 2026
Altshuler Shaham Ltd Added· Q1 2026 +3.0M Q1 2026
Parsifal Capital Management, LP · Exited
Change −2.8M Δ Own −100.0% Date Q1 2026
Parsifal Capital Management, LP Exited· Q1 2026 −2.8M −100.0% Q1 2026
Castle Hook Partners LP · Exited
Change −2.6M Δ Own −100.0% Date Q1 2026
Castle Hook Partners LP Exited· Q1 2026 −2.6M −100.0% Q1 2026
Data through Q1 2026 · filed Jun 10, 2026
15 of 581

Famous investor activity in Teva Pharmaceutical Industries Limited (TEVA)

Teva Pharmaceutical Industries Limited (TEVA) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Shields Matthew · Officer Sell −$322K
Price $32.19 Qty −10K Owned 0 ΔOwn −100.0% Trade date Jun 18, 2026 Filed date Jun 22, 2026
Shields Matthew Officer Sell $32.19 −10K −$322K 0 −100.0% Jun 18, 2026 Jun 22, 2026
Kalif Eliyahu Sharon · CFO Sell −$3.6M
Price $34.10 Qty −107K Owned 66K Trade date Jun 11, 2026 Filed date Jun 16, 2026
Kalif Eliyahu Sharon CFO Sell $34.10 −107K −$3.6M 66K Jun 11, 2026 Jun 16, 2026
Barer Sol J. · Director 2 operations 0
Owned 0 Trade date Jun 5, 2026 Filed date Jun 8, 2026
Barer Sol J. Director 2 operations 0 0 Jun 5, 2026 Jun 8, 2026
Lichtenstein Chen · Director 2 operations 0
Owned 0 Trade date Jun 5, 2026 Filed date Jun 8, 2026
Lichtenstein Chen Director 2 operations 0 0 Jun 5, 2026 Jun 8, 2026
Crane Rosemary A. · Director 2 operations 0
Owned 0 Trade date Jun 5, 2026 Filed date Jun 8, 2026
Crane Rosemary A. Director 2 operations 0 0 Jun 5, 2026 Jun 8, 2026
Elstein Amir · Director 2 operations 0
Owned 0 Trade date Jun 5, 2026 Filed date Jun 8, 2026
Elstein Amir Director 2 operations 0 0 Jun 5, 2026 Jun 8, 2026
Lieberman Gerald M. · Director 2 operations 0
Owned 0 Trade date Jun 5, 2026 Filed date Jun 8, 2026
Lieberman Gerald M. Director 2 operations 0 0 Jun 5, 2026 Jun 8, 2026
Nisen Perry · Director 2 operations 0
Owned 0 Trade date Jun 5, 2026 Filed date Jun 8, 2026
Nisen Perry Director 2 operations 0 0 Jun 5, 2026 Jun 8, 2026
Satchi-Fainaro Ronit · Director 2 operations 0
Owned 0 Trade date Jun 5, 2026 Filed date Jun 8, 2026
Satchi-Fainaro Ronit Director 2 operations 0 0 Jun 5, 2026 Jun 8, 2026
Zaks Tal Zvi · Director 2 operations 0
Owned 0 Trade date Jun 5, 2026 Filed date Jun 8, 2026
Zaks Tal Zvi Director 2 operations 0 0 Jun 5, 2026 Jun 8, 2026
Mignone Roberto · Director 2 operations 0
Owned 0 Trade date Jun 5, 2026 Filed date Jun 8, 2026
Mignone Roberto Director 2 operations 0 0 Jun 5, 2026 Jun 8, 2026
Francis Richard D. · Officer Sell −$211K
Price $34.35 Qty −6K Owned 1.2M Trade date Jun 5, 2026 Filed date Jun 8, 2026
Francis Richard D. Officer Sell $34.35 −6K −$211K 1.2M Jun 5, 2026 Jun 8, 2026
Francis Richard D. · Officer 2 operations 0
Owned 39K Trade date Jun 5, 2026 Filed date Jun 8, 2026
Francis Richard D. Officer 2 operations 0 39K Jun 5, 2026 Jun 8, 2026
Shields Matthew · Officer Sell −$532K
Price $32.87 Qty −16K Owned 10K Trade date Jun 3, 2026 Filed date Jun 4, 2026
Shields Matthew Officer Sell $32.87 −16K −$532K 10K Jun 3, 2026 Jun 4, 2026
Shields Matthew · Officer 2 operations 0
Owned 32K Trade date Jun 3, 2026 Filed date Jun 4, 2026
Shields Matthew Officer 2 operations 0 32K Jun 3, 2026 Jun 4, 2026
15 of 110
15 of 110 Sign in to continue to older insider transactions.

Teva Pharmaceutical Industries Limited (TEVA) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
FMR LLC 62.7M
% of shares outstanding 5.5% Filing date Nov 12, 2024
FMR LLC 62.7M 5.5% Nov 12, 2024
Phoenix Holdings Ltd. 54.1M
% of shares outstanding 4.8% Filing date Apr 9, 2024
Phoenix Holdings Ltd. 54.1M 4.8% Apr 9, 2024
Capital Research Global Investors
% of shares outstanding 0.0% Filing date Jun 9, 2023
Capital Research Global Investors 0.0% Jun 9, 2023
3 of 3

Teva Pharmaceutical Industries Limited (TEVA) ownership FAQ

Who owns TEVA?

581 reporting institutions disclosed TEVA position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.